Global Portable Lung Monitors Market is segmented By Product Type (Wearable Respiratory Monitoring, Respiratory Rate Monitoring, Blood Oxygen Monitoring, Other Monitoring), By Application (Asthma, Chronic obstructive pulmonary disease, Infectious Diseases, Others), By End-User (Hospital, Clinic, Household, Other), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Portable Lung Monitors Market Overview
180 pages report analyses the Portable Lung Monitors Market Share, Analysis and Growth. The Global Portable Lung Monitors Market is predicted to reach at a high CAGR during the forecast period (2023-2030). Portable Lung monitors are devices that provide medication to prevent and handle signs and assistance reduce worsenings of several lung conditions such as persistent obstructive lung illness (COPD) and asthma. North America region holds the largest market share. Competitive rivalry intensifies with GE Healthcare, Philips Healthcare, Medtronic and others operating in the market.
Portable Lung Monitors Market Scope
|
Metrics |
Details |
|
Market CAGR |
High |
|
Segments Covered |
By Product Type, By Application, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other vital insights. |
|
Largest Market Share |
North America |
For More Insights Download Sample
Portable Lung Monitors Market Dynamics
The portable lung monitors market growth is driven by the increasing infectious disease related to lungs, decrease in lungs oxygen holding capacity, high patient chronic disease related to lungs like (asthma, pneumonia). Lung monitoring devices might consist of either a single or a mix of drugs, such as a bronchodilator, a corticosteroid, a mix of various bronchodilators, or corticosteroids, respectively.
Source: DataM Intelligence Analysis (2020)
The increasing prevalence of chronic respiratory diseases, is expected to drive the growth in the forecast period
The major respiratory disorders currently cured using Portable Lung Monitors include Asthma, COPD, Bronchiectasis, cystic fibrosis, pulmonary arterial hypertension, and infectious pulmonary diseases. As per the Center for Disease Control and Prevention (CDC), around 16 million people suffer from COPD. As per CDC, in the last decade, the prevalence of asthma in the U.S. has increased by 15%. For example, 3.8 million people in Canada had asthma, and 2.0 million had the chronic obstructive pulmonary disease (COPD) in 2018. Respiratory diseases also lead to lost productivity and healthcare costs. The increasing burden of these diseases needs rapid intervention by increasing better treatment.
High cost of lung monitors is likely to hamper the market growth
The high cost of lung monitors $2,070, the recurring cost of operation of $735 are likely to hinder the market growth.
COVID-19 Impact On Portable Lung Monitors Market
The World Health Organization (WHO), on January 30, 2020, declared the COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. According to a paper published by the Journal of Allergy and Clinical Immunology (JACI), in 2020, asthma and COPD patients appear to have increased their adherence to inhalation medications during the COVID-19.
Moreover, some parts of developed countries such as the U.S. and the U.K. are experiencing shortages of bronchodilator inhalers such as albuterol inhalers, as hospitals utilize them for COVID-19 patients. Furthermore, according to data provided by the National Health Service (NHS), in 2020, the number of salbutamol inhalers prescribed by general practitioners (G.P.) in England raised by 63% between February 2020 and March 2020. Thus, COVID-19 infection uplifted growth and opportunities for manufacturers of the portable lung monitors market during the forecast period.
Portable Lung Monitors Market Segment Analysis
The wearable respiratory monitoring segment is expected to hold largest share in this market segment
Global Portable Lung Monitors Market – By Product Type
- Respiratory Rate Monitoring
- Wearable respiratory monitoring
- Blood Oxygen Monitoring
- Other Monitoring
Global Portable Lung Monitors Market - By Application
- Asthma
- Chronic obstructive pulmonary disease
- Infectious Diseases
- Others
Global Portable Lung Monitors Market – By End-User
- Hospital
- Clinic
- Household
- Other
Global Portable Lung Monitors Market - By Region
- North America
- Europe
- Asia-Pacific
- Middle East & Africa
- South America
Wearable respiration monitors developed for these purposes are small and discrete, making application and wear easy for the patient. The wearable respiratory monitoring system is a comfortable chest strap that continuously and accurately monitors the patient's respiratory patterns, whether in the hospital, at home, exercising, traveling, or in a living facility.
For instance, Resmetrix Medical has developed a novel wearable respiratory monitoring system, that accurately monitors the respiratory pattern of respiratory disease patients (COVID-19, COPD, Asthma) and alert to the patient smartphone, and the medical team, when early signs of respiratory deterioration occur.
The asthma segment is expected to hold largest share in this market segment
The asthma segment had the highest share in the application segment. Asthma was highly prevalent around the world and affected 262 million people in 2019. From all lung diseases in the U.S., asthma is most common. Asthma is a long-term condition where the air passages in the lungs are partially blocked due to inflammation and muscle tightening. Symptoms of asthma include wheeze, cough, shortness of breath and tightness in the chest.
The hospitals segment is expected to hold largest share in this market segment
The most common end-users are hospitals. Every year there are approximately 800,000 hospitalizations for Chronic obstructive pulmonary disease (COPD) in the United States, the third leading cause of death in the country. Additionally, 500,000 hospitalizations for asthma occur yearly and affect about 24 million Americans. Treatments for both COPD and asthma have similar protocols which have been well established over the years.
Source: DataM Intelligence Analysis (2020)
Portable Lung Monitors Market Geographical Share
North America region holds the largest market share of global portable lung monitor’s market
The U.S. is one of the largest markets for portable lung monitors globally. The U.S. is the hub of medical devices. This market is set to grow with the high pitch in the forecast period due to continuous research in this field in the U.S., making it a most lucrative market. Due high prevalence of lung disorders like COVID-19, asthma, bronchitis, pneumonia, chronic obstructive pulmonary disease, COPD, this factor is the key driver of the Portable Lung Monitors market. Around 35 Mn Americans have chronic lung disease, As per American Lung Association. Among all lung diseases in the U.S., asthma is most common, 25 Mn, followed by interstitial lung disease 12 Mn and chronic obstructive pulmonary disease (COPD) 11 Mn.
Source: DataM Intelligence Analysis (2020)
Portable Lung Monitors Market Companies and Competitive Landscape
The global portable lung monitors market is highly competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include GE Healthcare, Philips Healthcare, Medtronic, ResMed, Siemens Healthcare, Merck & Co., Calando Pharmaceuticals, Quark Pharmaceuticals, Sirnaomics Inc, Traversa Therapeutics. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in May 2021 Siemens accelerates digital marketplace strategy with acquisition of Supply frame.
Portable Lung Monitors Market Key Companies to Watch
GE Healthcare
Overview: GE Healthcare is a subsidiary of American multinational conglomerate General Electric incorporated in New York and headquartered in Chicago, Illinois. As of 2017, the company is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures. The company offers dyes that are used in magnetic resonance imaging procedures. GE Healthcare also manufactures medical diagnostic equipment, including CT image machines.
Product Portfolio: It develops health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing.
Why Purchase the Report?
- Visualize the composition of the portable lung monitors market segmentation by product type, application, end-user and region highlighting the key commercial assets and players.
- Identify commercial opportunities in portable lung monitors market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of portable lung monitors market - level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key product of all major market players
The global portable lung monitors market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.
Target Audience
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers
